Insider · CIK 0001551139

667, L.P.

CIK 0001551139 Name as filed on the most recent filing

Filed as 667, L.P. (185)

2,117 transaction lines · from 185 filings · filed 2012-10-31 to 2026-05-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 837,371, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 428,559, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 424,108, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 302,419, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 244,152, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 229,562, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 168,268, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 105,030, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 26,023, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 11,930, acquired Open Form 4 filing 0001638599-17-000613
2017-06-14 P, Open-market purchase Alexion Pharmaceuticals IncALXN 2 lines 518,256, acquired Open Form 4 filing 0001638599-17-000614
2016-11-18 P, Open-market purchase BeiGene, Ltd.BGNE 2 lines 56,335,840, acquired Open Form 4 filing 0001638599-16-001591
2016-11-08 P, Open-market purchase Seattle Genetics Inc /WASGEN 2 lines 19,403,299, acquired Open Form 4 filing 0001638599-16-001514
2016-11-07 P, Open-market purchase Seattle Genetics Inc /WASGEN 2 lines 3,301,345, acquired Open Form 4 filing 0001638599-16-001514
2016-11-03 P, Open-market purchase Seattle Genetics Inc /WASGEN 4 lines 21,586,884, acquired Open Form 4 filing 0001638599-16-001487
2016-11-03 P, Open-market purchase Seattle Genetics Inc /WASGEN 8 lines 11,196,763, acquired Open Form 4 filing 0001638599-16-001488
2016-11-02 P, Open-market purchase Seattle Genetics Inc /WASGEN 10 lines 26,200,958, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 4,688,039, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 2,192,976, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 1,755,578, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 513,387, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 240,166, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 192,262, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 149,479, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 129,815, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 98,455, acquired Open Form 4 filing 0001638599-16-001487
2016-11-01 P, Open-market purchase Seattle Genetics Inc /WASGEN 50,365, acquired Open Form 4 filing 0001638599-16-001487

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. 667, L.P., insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001551139

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.